The Interaction between Human Microbes and Advanced Glycation End Products: The Role of Klebsiella X15 on Advanced Glycation End Products’ Degradation

Aiying Shi, Xuemeng Ji, Wanhua Li, Lu Dong, Yuekun Wu, Yunhui Zhang, Xiaoxia Liu, Yan Zhang, Shuo WangNutrients 2024 · DOI

TL;DR

This study investigates how human gut microbes interact with advanced glycation end products (AGEs), specifically focusing on the degradation of protein-bound AGEs by Klebsiella X15. The research reveals that Klebsiella can effectively utilize AGEs as a sole nitrogen source, leading to significant metabolic shifts and proliferation, suggesting a key role for this bacterium in AGEs' impact on gut health and disease.

What Problem Does This Paper Address?

Advanced Glycation End Products (AGEs) are formed through non-enzymatic reactions and are implicated in various diseases, including diabetes and Alzheimer's. While dietary AGEs are known to be associated with intestinal disorders, the precise mechanisms of their interaction with the human gut microbiota remain largely unclear. Previous research has primarily focused on free AGEs, overlooking the more prevalent protein-bound forms found in food. This study aims to bridge this gap by exploring how human gut microbes, particularly specific bacterial strains, can metabolize and degrade protein-bound AGEs, and how this interaction influences the gut microbial community and host health.

Methods

The researchers employed a multi-pronged approach:

  • AGE Preparation: Methylglyoxal-beta-lactoglobulin AGEs (MGO-β-LG AGEs) were synthesized and characterized.
  • In Vitro Digestion: A simulated gastrointestinal digestion model was used to mimic human digestion of MGO-β-LG AGEs.
  • Anaerobic Fermentation: Fecal slurries from healthy human volunteers were incubated with the digested AGEs as the sole nitrogen source under anaerobic conditions.
  • Microbial Community Analysis: 16S rRNA sequencing was used to track changes in the gut microbiota composition over time during fermentation.
  • Bacterial Isolation and Screening: Potential AGE-metabolizing bacteria were isolated from the fermentation broth. Their growth was assessed using optical density measurements when AGEs were the sole nitrogen source.
  • AGE Degradation Analysis: Liquid chromatography-mass spectrometry (LC-MS) was used to quantify the reduction of specific AGEs (CML and CEL) in the fermentation broth.
  • Proteomic Analysis: High-resolution mass spectrometry was employed to compare protein expression profiles of Klebsiella X15 grown on AGEs versus unmodified proteins, revealing metabolic adaptations.

Datasets

  • Human Fecal Samples: Samples were collected from 12 healthy volunteers (5 male, 7 female, aged 21-30) with no history of gastrointestinal diseases or recent antibiotic use.
  • Microbial Sequencing Data: 16S rRNA sequencing data from the fermentation experiments were submitted to the NCBI Sequence Read Archive (SRP484236).
  • Proteomics Data: Mass spectrometry proteomics data were deposited to the ProteomeXchange Consortium via the iProX partner repository with the dataset identifier PXD048590.

Key Insights and Ideas

  • Gut Microbiota's Appetite for AGEs: The study demonstrates that human gut microbes, particularly Klebsiella, can actively degrade and utilize protein-bound AGEs as a primary nitrogen source. This is a significant finding, as it moves beyond the understanding of free AGE metabolism.
  • Klebsiella as an AGE Metabolizer: A specific strain, Klebsiella X15, showed remarkable growth when AGEs were its sole nutrient, suggesting a specialized metabolic pathway and a competitive advantage in AGE-rich environments.
  • Microbial Community Shift: The presence of AGEs significantly altered the gut microbial community structure, leading to a dramatic increase in Klebsiella proliferation and shifts in dominant genera. This highlights the potential for AGEs to reshape the gut ecosystem.
  • Metabolic Reprogramming: Proteomic analysis revealed that Klebsiella X15 undergoes substantial metabolic changes when utilizing AGEs, particularly in amino acid and energy metabolism pathways, indicating a sophisticated adaptation strategy.
  • Implications for Disease: The observed increase in Klebsiella, a known opportunistic pathogen, and the link between AGEs and intestinal inflammation, suggest a potential mechanism by which dietary AGEs contribute to gut-related diseases.

Key Results

  • AGE Degradation: Fermentation with human fecal microbiota and Klebsiella X15 led to a significant reduction in CML and CEL content, confirming AGE degradation.
  • Microbial Diversity Changes: During fermentation, alpha-diversity metrics (species richness and diversity) initially decreased and then recovered, with notable shifts in dominant genera.
  • Klebsiella Dominance: Klebsiella emerged as a dominant genus, showing significant proliferation when AGEs were the sole nitrogen source.
  • Bacterial Isolation: 187 potential AGE-metabolizing bacterial strains were isolated, with Klebsiella X15 showing the most robust growth.
  • Proteomic Changes: Proteomics identified 254 proteins with significantly increased expression in Klebsiella X15 when utilizing AGEs, primarily involved in amino acid and energy metabolism.

Limitations and Future Work

  • In Vitro Model: The study was conducted using an in vitro model, which may not fully replicate the complex in vivo environment of the human gut.
  • Specific AGEs: The study focused on MGO-β-LG AGEs. Further research is needed to understand the metabolism of other types of AGEs.
  • Host-Microbe Interaction: While the study highlights microbial changes, the direct impact of these AGE-metabolizing bacteria on host physiology and disease development requires further investigation.
  • Future Directions: The authors suggest further exploration into the specific enzymes and metabolic pathways involved in AGE degradation by Klebsiella and other gut bacteria. Investigating the long-term effects of AGE consumption on the gut microbiota and host health in vivo is also a crucial next step.

Summary updated

Abstract

Previous studies have shown that advanced glycation end products (AGEs) are implicated in the occurrence and progression of numerous diseases, with dietary AGEs being particularly associated with intestinal disorders. In this study, methylglyoxal-beta-lactoglobulin AGEs (MGO-β-LG AGEs) were utilized as the exclusive nitrogen source to investigate the interaction between protein-bound AGEs and human gut microbiota. The high-resolution mass spectrometry analysis of alterations in peptides containing AGEs within metabolites before and after fermentation elucidated the capacity of intestinal microorganisms to enzymatically hydrolyze long-chain AGEs into short-chain counterparts. The 16S rRNA sequencing revealed <i>Klebsiella</i>, <i>Lactobacillus</i>, <i>Escherichia-Shigella</i>, and other genera as dominant microbiota at different fermentation times. A total of 187 potential strains of AGE-metabolizing bacteria were isolated from the fermentation broth at various time points. Notably, one strain of <i>Klebsiella</i> exhibited the most robust growth capacity when AGEs served as the sole nitrogen source. Subsequently, proteomics was employed to compare the changes in protein levels of <i>Klebsiella</i> X15 following cultivation in unmodified proteins and proteins modified with AGEs. This analysis unveiled a remodeled amino acid and energy metabolism pathway in <i>Klebsiella</i> in response to AGEs, indicating that <i>Klebsiella</i> may possess a metabolic pathway specifically tailored to AGEs. This study found that fermenting AGEs in healthy human intestinal microbiota altered the bacterial microbiota structure, especially by increasing <i>Klebsiella</i> proliferation, which could be a key factor in AGEs' role in causing diseases, particularly intestinal inflammation.
BibTeX
@inproceedings{shi2024interaction,
  author = {Aiying Shi and Xuemeng Ji and Wanhua Li and Lu Dong and Yuekun Wu and Yunhui Zhang and Xiaoxia Liu and Yan Zhang and Shuo Wang},
  title = {{The Interaction between Human Microbes and Advanced Glycation End Products: The Role of Klebsiella X15 on Advanced Glycation End Products’ Degradation}},
  booktitle = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16050754},
}
Figure